Eng Nor
Meny

Bruk av selektive serotoninreopptakshemmere i graviditet, og effekt på foster og nyfødt: en metaanalyse

Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and effects on the fetus and newborn: a meta-analysis

Authors
Lattimore, K. A. Donn, S. M. Kaciroti, N. Kemper, A. R. Neal, C. R. Vazquez, D. M.
Year
2005
Journal
Journal of Perinatology
Volume
25
Pages
595-604
Link to the publication
https://doi.org/10.1038/sj.jp.7211352
Selective serotonin reuptake inhibitors (SSRIs) are frequently used to treat depression during pregnancy and the postpartum period. These drugs are capable of crossing the placenta and being transferred to the newborn during lactation. This report reviews the available information regarding the effects of SSRIs on the fetus and newborn; including long-term neurodevelopmental outcomes.

Oversett med Google Translate
-
Type of intervention

Treatment and Child Welfare Interventions

Topic

Mental Health Problems and Disorders

Emotional Problems

Depression and Depressed Mood

Development and Life Coping Skills

Cognition

Biological Risk Factors, Diseases and Symptoms

Pregnancy

Intervention

Pharmacological Treatment

Antidepressants

Psychosocial Treatments

Interventions for Pregnant Women and Postpartum Women

Age group

Infants and Toddlers (0-2 years)

Print Order AMSTAR-review (e-mail)
More information
Looking for more information on this topic? Click on the links below to search PsykTestBarn and Håndboka